S T A T E O F N E W Y O R K
________________________________________________________________________
10739
I N S E N A T E
November 13, 2026
___________
Introduced by Sen. CLEARE -- read twice and ordered printed, and when
printed to be committed to the Committee on Rules
AN ACT to amend the elder law, in relation to eligibility for the
program for elderly pharmaceutical insurance coverage
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Paragraph (f) of subdivision 3 of section 242 of the elder
law, as amended by section 1 of part T of chapter 56 of the laws of
2012, is amended to read as follows:
(f) As a condition of eligibility for benefits under this title, a
program participant is required to be enrolled in Medicare part D IF
ELIGIBLE and to maintain such enrollment IF ELIGIBLE. For unmarried
participants with individual annual income less than or equal to twen-
ty-three thousand dollars and married participants with joint annual
income less than or equal to twenty-nine thousand dollars, the elderly
pharmaceutical insurance coverage program shall pay for the portion of
the part D monthly premium that is the responsibility of the partic-
ipant. Such payment shall be limited to the low-income benchmark premium
amount established by the federal centers for medicare and medicaid
services and any other amount which such agency establishes under its de
minimus premium policy.
§ 2. Subdivision 4 of section 242 of the elder law, as added by
section 12-a of part T of chapter 56 of the laws of 2012, is amended to
read as follows:
4. As a condition of eligibility for benefits under this title,
participants must be enrolled in medicare part D IF ELIGIBLE and main-
tain such enrollment IF ELIGIBLE. For persons who meet the eligibility
requirements to participate in the elderly pharmaceutical insurance
coverage program, the program will pay for a drug covered by the
person's medicare part D plan or a drug in a medicare part D excluded
drug class, as defined in subdivision eight of section two hundred
forty-one of this title, provided that such drug is a covered drug, as
defined in subdivision one of section two hundred forty-one of this
title, and that the participant complies with the point of sale co-pay-
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD16545-01-6
S. 10739 2
ment requirements set forth in sections two hundred forty-seven and two
hundred forty-eight of this title. No payment shall be made for medicare
part D plan deductibles.
§ 3. This act shall take effect April 1, 2027.